Abstract:Conditional gene inactivation and restoration are powerful tools for studying gene functions in the nervous system and for modeling neuropsychiatric diseases. The combination of the two is necessary to interrogate specific cell types within defined developmental stages. However, very few methods and animal models have been developed for such purpose. Here we present a versatile method for conditional gene inactivation and in situ restoration through reversibly inverting a critical part of its endogenous genomic sequence by Cre- and Flp-mediated recombinations. Using this method, we generated a mouse model to manipulate Mecp2, an X-linked dosage-sensitive gene whose mutations cause Rett syndrome. Combined with multiple Cre- and Flp-expressing drivers and viral tools, we achieved efficient and reliable Mecp2 inactivation and restoration in the germline and several neuronal cell types, and demonstrated phenotypic reversal and prevention on cellular and behavioral levels in male mice. This study not only provides valuable tools and critical insights for Mecp2 and Rett syndrome, but also offers a generally applicable strategy to decipher other neurologic disorders. SIGNIFICANCE STATEMENT Studying neurodevelopment and modeling neurologic disorders rely on genetic tools, such as conditional gene regulation. We developed a new method to combine conditional gene inactivation and restoration on a single allele without disturbing endogenous expression pattern or dosage. We applied it to manipulate Mecp2, a gene residing on X chromosome whose malfunction leads to neurologic disease, including Rett syndrome. Our results demonstrated the efficiency, specificity, and versatility of this new method, provided valuable tools and critical insights for Mecp2 function and Rett syndrome research, and offered a generally applicable strategy to investigate other genes and genetic disorders.

CRISPR/Cas9 knock‐in toward creating a Rett syndrome cell model with a synonymous mutation in the MECP2 gene

Downregulation of CNPase in a MeCP2 Deficient Mouse Model of Rett Syndrome.

Selective Preservation of Cholinergic Mecp2 Rescues Specific Rett-Syndrome-Like Phenotypes in Mecp2(Stop) Mice

A novel pathogenic mutation of MeCP2 impairs chromatin association independent of protein levels

Molecular Genetic Study of MECP2 Gene for a Patient with Typical Rett Syndrome

Mutations in MECP2 Exon 1 in Classical Rett Patients Disrupt MECP2_e1 Transcription, but Not Transcription of MECP2_e2

Cell-Type-Specific Gene Inactivation and in Situ Restoration Via Recombinase-Based Flipping of Targeted Genomic Region

Testing the PEST hypothesis using relevant Rett mutations in MeCP2 E1 and E2 isoforms

Rett Syndrome Linked to Defects in Forming the MeCP2/Rbfox/LASR Complex in Mouse Models

Non-canonical C-terminal variant of MeCP2 R344W exhibits enhanced degradation rate

Rett Syndrome Mutation Mecp2 T158a Disrupts Dna Binding, Protein Stability and Erp Responses

Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations

Detection of Rare Methyl-CpG Binding Protein 2 Gene Missense Mutations in Patients With Schizophrenia

MECP2 Gene Mutation Analysis in Chinese Patients with Rett Syndrome

Generation and characterization of a human neuronal in vitro model for Rett Syndrome using a direct reprogramming method

Mutational Analysis of MECP2 Gene in Rett Syndrome

MECP2 and CDKL5 Gene Mutation Analysis in Chinese Patients with Rett Syndrome

Targeted RNA editing in brainstem alleviates respiratory dysfunction in a mouse model of Rett syndrome

The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis

Site-blocking antisense oligonucleotides as a mechanism to fine-tune MeCP2 expression

Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome